Multiple Sclerosis Clinical Trials

Showing 241-260 of 5,960 trials

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

NCT05605535

A clinical study to compare the efficacy and safety of five administrations of oregovomab versus placebo, infused in schedule dependent sequence with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of patients with newly diagnosed advanced ovarian cancer who are planned to receive neoadjuvant treatment followed by interval debulking surgery (IDS) and adjuvant treatment.

Ovarian Neoplasm EpithelialOvarian CancerFallopian Tube Neoplasms+2 more

CanariaBio Inc.88 participantsStarted Feb 2023

Visakhapatnam, Andhra Pradesh, India • Visakhapatnam, Andhra Pradesh, India • Vadodara, Gujarat, India +11 more locations

RECRUITING

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

NCT05344469

This is an observational, non-interventional, multicenter, open-label study in patients being treated with any approved injectable or selected oral DMT for RMS in Germany. Prospective, primary data will be collected via questionnaires and an electronic case report form (eCRF) over a period of up to four years. Additionally, medical history of participants will be collected including disease duration, laboratory values, EDSS, MRI parameters and relapses.

Relapsing Multiple Sclerosis

Novartis Pharmaceuticals800 participantsStarted May 2022

Hettingen, Baden-Wurttemberg, Germany • Mannheim, Baden-Wurttemberg, Germany • Nagold, Baden-Wurttemberg, Germany +116 more locations

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Related Searches

A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

New Technique of Pancreaticojejunostomy During Whipple Operation

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy

Rare Group Problem Management Plus

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Mayo Clinic Upper Digestive Disease Survey

Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

Use of Fluorescence in Gliomas

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients